MHRA Launches Consultation on Modernising the Definition of Gene Therapy Medicinal Products
Read the full articleYou might also wanna read
UK Government Considers New Regulations for AI-Powered Medical Devices in Healthcare
The MHRA is seeking evidence on the regulation of AI in healthcare to inform the recommendations of the National Commission into the Regulat
gov.uk·27d ago
ASO biotech wants MHRA to go further in new rare disease therapy framework
CEO of SynaptixBio thinks the MHRA could do more to support UK rare disease drug innovation.
bioprocessintl.com·28d ago
FDA Draft Guidance Allows Gene Therapy Companies to Leverage Existing Data for Faster Product Approvals
On June 2, the US Food and Drug Administration (FDA) released a new draft guidance called “Leveraging Prior Knowledge in the Development of
jdsupra.com·28d ago
FDA releases draft guidance to accelerate gene therapy development
The agency seeks to help streamline development while maintaining rigorous safety standards.
bioprocessintl.com·1mo ago
Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
Consultants from ProPharma express optimism about the trajectory of cell and gene therapy despite technical and logistical difficulties rema
bioprocessintl.com·24d ago
STAT+: Roche ends Huntington’s gene-silencing programs
ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The Readout
STAT·20h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.